attention

production

Anavex Life Sciences Corporation

wait

Seems crazy to me to unjust approvals that are going on while we wait on legitimate results!!!

But why wait 3 years with that when Anavex 50mg dose is likely better! !

So, if one waits months for an answer and then has to resubmit to another journal it can hold things up.

This is a shitshow till data is presented.

loss

but  losses  and  disappointment  with  Missling.

$AVXL Took my $250 loss and Got out guys too much noise not enough action.

but was faked by the move and held them to expiration and had to book a loss of $19,000.

shareholder

The krout has proven to be an a hole toward shareholders.

Missling is a greedy pig, doesnt see the bad he does by delaying intentionally, not only to shareholders,

i am telling for years that we need to fire that shitty guy just here to full his pockets without any consideration for his shareholders.

.this guy doesnt respect his shareholders and he must be sue for that.

$AVXL fire Missling, he has been here 9 years and done nothing to drive shareholder value other than BS hype

$AVXL why does the company not believe they are beholden to their shareholders?

$AVXL Unfortunately the Investorshub AVXL board has deteriorated to the point that it is basically a board consisting of almost entirely FUD with almost more bashers than true shareholders.

Messling is grossly deficient in anticipating the expectations of shareholders and the market.

$AVXL as corporate shareholder, I have sent an email on dec. 21st and a friendly reminder yesterday to IR - no response yet !!

One hand he says he care for shareholder value, on other hand he is purposely not sharing updates.

shareprice

$AVXL missling next time should change a few letters when hiring and SP will improve: from FDA to FBI former employee.

$AVXL Every time Missling speaks, the SP tanks…..amateurish communication, unbelievable.

It&#39;s stupid, it wastes time (and $$$) and it leaves the company vulnerable with a supressed SP.

Based on Rett alone, SP is well under 100$, sorry to bust your ballown,but please try to stay realist and keep a little credibility!

$AVXL The sp is wrong there must be a glitch

$AVXL not that i am happy with the SP overall

$AVXL Until you realize that and admit that the presenter screwed up in rushing the presentation the SP will stay where it’s at

$AVXL wandering when we will cross ANVS SP ;) 
never again!!!!

$AVXL we didnt cross ANVS SP yet, no good haha!

show

Take your money from this shit show and deposit in your bank account.

What an absolute unregulated criminal shit show this market has become.

Missling shows poor judgement and is not suited to be ceo.

SHOWS THE EXTREME WEAKNESS AND  DISTRESS THE STOCK IS UNDER.

but need more time to evaluate and announce a conference call for Monday instead we have a shit show.

Strongly recommend giving this your attention if you’re invested here or considering a position. https://www.sotcanalytics.com/

$AVXL we have been getting alot of attention lately which is a very good thing.

$AVXL This is definitely going to get the attention of a big investor.

$AVXL Goods news are spreading and Anavex is getting more attention day after day.

It is the perfect timing set to have the attention of Wall Street and to be in the spotlights the whole week long, offering free champagne to everyone at CTAD.

but it will attract attention of investors especially with the mention of th $20 billion bump in value that Biogen got for their recent FDA drug approval.

If nothing else this pop is going to get attention.

Anavex is late like the sun comes up and still produces great results.

Remi (mostly his handlers, praise be) will take all the time they need to package it correctly and produce it in a way that even Madam Fürherstain won’t be able to besmirch,

Blarcamesine is More effective, safer, cheaper to produce, and easier to administer than any late stage big pharma Alzheimer treatment EVER.

business-result

Anavex&#39;s A2-73 Blarcamesine&#39;s trial results on 2 previously completed adult phase-3 trials were highly successful.

But the company actually has never seen before wonderful results.

If results hold up, the stock will achieve massive gains.

The results were excellent on the 2 completed adult trials, and because the 3rd trial is pediatric and early on the disease, they are expected to perform even better.

Alzheimer&#39;s is the most valuable and most difficult indication and most desired lately..  and only Anavex really has some great results with a great safety record. .

The  sava  results  trounce  you  guys  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

Sava has potential and the phase 3 results will show the truth.

drug

- Timo grimmer is in the team 
- All endpoints of the clinical trial were reached 
 
I firmly believe that the drug works and that the CEO has done a good job no matter how much he is criticized.

we have a drug, even many drugs, good for so many indications,  to become a giant pharma, we are about to get billions in revenues.

$AVXL The improvements in the drug arm cannot be lucky. .

I&#39;m looking forward to seeing the long term AD data on ANVS and have the feeling it&#39;s going to end up being the best in class AD treatment as well.

Do not listen to any FUD this drug is the real deal.

$AVXL amazing to see the actual benefits to people and their families of this “miracle drug” as they call it

$AVXL Dr. Perry said we have a legendary drug which actually reverses AD and is safe unlike Adulhelm.

trial

$AVXL amazing  avxl  still  in  singke  digits  after  a  supposedly  amazing  “pivotal”  trial  readout  🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂😂

$AVXL The trial met both co-primary and secondary endpoints showing statistically significant reduction of clinical decline as measured by those endpoints.

$AVXL Australia trial data meets the gold standard.

2-73 has orphan designation for Rett which combined with the multiple Rett trials and it very good safety record should make it a great candidate for AA.

This company has yet to fail to meet endpoints on any trial and the thousands of papers on the MOA  eliminates fraud with science, and the company is in great fiscal shape so no shenanigans there.

Arcimoto Inc

BTB looks to be getting alot of attention! 🙂

We are excited to announce we have started production on our 2023 FUV and Deliverator with first deliveries starting in March!

$FUV looking good to resume its factory operations

news

This trades well, .80 - 1.10 over and over
$SNMP 1.8mil rocket and flagging 
$FUV 1.1mil watching 2.12 reaction
   $GROM 4.7mil mover on news

Grom and snmp best overnight play ideas imo 💡🦾

Any good news could make the stock go up and gain hundreds percent!

I will sell $pixy around $22

I think that is where this is headed 

 $FUV damn nice

 $BBLG damn nice 

 $NRBO entry low 70s

 $KSPN chart is point to an event or news

$TCBP great news low float taking off
$FUV not bad

Hit 133% profit overnight! 💰💰 
 
⬇️For more Targets &amp; Stock News ⬇️ 
https://stockresearchtoday.com/massive-bounce-potential-for-this-one-tech-stock/ 
 
Communicated Disclaimer (always set stops and take profit!)

$FUV  
Good news, Mark is very hard at work ;)

product

Headlining the model year 2023 product update is the new steering system that will deliver improved handling and maneuverability at all speeds while reducing steering effort by more than 40% from prior models.

Seems like they are going to make this product successful.

As we continue our efforts directed on our core products, the FUV and Deliverator, we’re excited to unveil new features to each vehicle, improving overall ride quality, performance, and polish.

Was hoping for the best for them they seemed to have a great product and bright future.

$FUV less desirable product than $SOLO and that’s quite and achievement.

$FUV  … hate to see this product go down.

vehicle

As we get ready for Spring deliveries: 2023 vehicles come with some new features and improvements.

$FUV nice opportunity after offering at $3 electric power play 🚀🚀

The D1 is just about as cost-effective as it gets for local delivery, especially compared to large, legacy ICE delivery vehicles.

Companies plan on using these vehicles to make driverless deliveries in turn for huge profits and shares are sure to climb right back up as soon as markets recover.

$FUV Seems to be gaining some popularity ground in delivery circles, that&#39;ll surly make fleet sales much easier.

Enovix Corporation

company

Company is severely capital constrained so very risky currently.

I can think of: 
1. plan to take company private 
2. they are dumber than shit 
 
So, only one negative reason I can think of as to why they are buying.

.. btw  State of michigan  secretly  giving 750 millon tax payer dollars to a chineese battery company to set up shop in michigan .. i for one am outraged by this and the sellout of our country by biden and his loones .

How can a company with advanced battery tech make such a naive mistake on publishing paper?

Almost always a death sentence to the company.

$ENVX I usually do not care, wouldn&#39;t even want the company to waste the energy/time or give the firms any merit .

The company needs to hit some key milestones now and communicate them.

The stock is tanking because the company has nothing real to show for the quarter.

Did I just run into a great buying opportunity 
OR 
Does this company suck eggs?

short

$ENVX and there is a reason shorts should be shitting their pants.

I get the shorts are desperate..but man it&#39;s pathetic.

$ENVX Shorty is like a drunk playing on the train tracks.

$ENVX cover up shorts!! It’s going to get ugly for the shorts real fast :))

$DLO  after this sht and SHORT REPORT seriously i feel like never ever touch and DESPACs does not matter how good they are.

$ENVX the shorts, especially in here, have been smoked lol

dilution

if I wasn&#39;t already bummed with this fat loss.

risk

$ENVX Here are a couple reasons why ENVX can actually be extremely bullish in a bearish market: 
 
1)  BrakeFlow - what other next generation battery has passed the nail test that is currently in production?

opportunity

I am as bullish as ever, and will add when the market provides the best opportunity.

Because their pipeline is huge and that opportunity will not be wasted.

Very happy with the opportunity here last 3 days.

$ENVX this is such a good opportunity to buy at the low price, once we are above 30 people will be wishing they bought at this level

$ENVX very pleased I had the opportunity to add to my position under $11, would&#39;ve liked more around $8

.buying opportunity of a effing lifetime !!! !

$ENVX good opportunity to buy-in. Thanks.

Probably a great buying opportunity here for a long term hold if they can execute though.

term

I absolutely love the long term mindset and this will take sometime

I believe in this company for the long term

$JOBY $EH $ENVX 
Super bullish long term on all 3!

Always happy to see so many long terms bulls I have known for a while being rewarded.

however, as long as TJ doesn’t sell I remain confident in the long term trajectory.

🔹 Possible Bottom 🔹

🎯 The short term EMAs on $ENVX seem to be turning.

$ENVX  To me this is beautiful for my long term port .. watching the DCB to the 786 level to the &quot;T&quot; .

buying

$ENVX 
Up nearly 10% since this idiot posted yet another one of his idiotic posts.. same guy who said:
“Buying calls on Enovix is stupid!” 
I think you are stupid!

$ENVX good chance TJ&#39;s buying more today.

$ENVX  Call buying activity is pointing towards a potential upward move in the stock We are seeing the $10 CALL having heavy activity which expire in 124 days.

$ENVX  Call buying activity is pointing towards a potential bullish move in the stock We are seeing the $0.03311867525299 0.360000000000001 having heavy activity which expire in 17431 days.

$ENVX TJ buying in again has convinced me to take a position here.

$ENVX wow, the way insiders are buying, it seems something big on way 👍🤑🤑🤑

Great news at the end of last week, insider buying on Friday and bulking out the team today.

Top Stocks matching your search for "attention production"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Jan, 14, 2023

Jan, 12, 2023

FUV

Arcimoto Inc

-36.62%

$2.13 - $1.35

Jan, 23, 2023

ENVX

Enovix Corporation

30.44%

$8.87 - $11.57

AVXL

Anavex Life Sciences Corporation

-22.55%

$11.75 - $9.10

Jan, 14, 2023

Jan, 12, 2023

Dec, 6, 2022

Dec, 4, 2022

Nov, 24, 2022

Nov, 13, 2022

Oct, 24, 2022

Oct, 17, 2022

FUV

Arcimoto Inc

-36.62%

$2.13 - $1.35

ENVX

Enovix Corporation

30.44%

$8.87 - $11.57